novavax vaccine

A new COVID vaccine will now be available in the U.S. after health officials recommended it Tuesday.

The U.S. is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday cleared Novavax shots for adults.

Americans may soon get a new COVID-19 vaccine option — shots made with a more tried-and-true technology than today’s versions. Novavax received approval from the Food and Drug Administration for its COVID-19 vaccine Wednesday.

Americans may soon get a new COVID-19 vaccine option — shots made with a more tried-and-true technology than today’s versions.

The U.S. could soon have a new COVID vaccine on the market but this one will be different from the others.

Centers for Disease Control and Prevention Director Dr. Rochelle Walensky says she doesn’t believe the U.S. has reached the peak of the omicron coronavirus wave impacting the country.

AstraZeneca released new data on its U.S. trial Monday as the company prepares to submit its findings to the U.S. Food and Drug Administration for emergency use authorization.

NIAID Director Dr. Anthony Fauci says the Food and Drug Administration will “place a great deal of scrutiny” on data from the AstraZeneca COVID-19 trial.

As Chicago prepares to expand its vaccine eligibility, with hopes that additional supply becomes available, questions linger over the potential for additional vaccines.

AstraZeneca has been eyeing a spring approval in the U.S. for its COVID vaccine, but as the shot sits at the center of concerns in Europe, with countries divided over how to handle the rollout, could that impact what happens here?

Though the U.S. already has three approved COVID vaccines being distributed across the country, there have been some discussions about two others circulating elsewhere in the world: the AstraZeneca vaccine and the Novavax vaccine.

With a third coronavirus vaccine now approved in the U.S., what is the difference between the vaccines and should you opt for one over the other?